3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
9
Phase NA
6
Phase 1
6
Phase 3
2
Phase 1/2
2
Status
Not yet recruiting
1
Completed
1
Sponsor Class
INDUSTRY
95
OTHER
36
NIH
16
NETWORK
9
OTHER_GOV
2
Study Type
Interventional
2
Sponsor
Cancer Type
Dermatologic
2
Conditions
Breast Neoplasms
17
Uterine Cervical Neoplasms
11
Stomach Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Ovarian Neoplasms
8
Neoplasms
8
Esophageal Neoplasms
8
Carcinoma, Ovarian Epithelial
7
Fallopian Tube Neoplasms
6
Colorectal Neoplasms
5
Recurrence
4
Neoplasm Metastasis
4
Multiple Myeloma
4
Mouth Neoplasms
4
Head and Neck Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Hepatocellular
4
Rectal Neoplasms
3
Nasopharyngeal Carcinoma
3
Lymphoma, Non-Hodgkin
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Glioblastoma
3
Esophageal Squamous Cell Carcinoma
3
Urinary Bladder Neoplasms
2
Prostatic Neoplasms
2
Polycystic Ovary Syndrome
2
Peripheral Nervous System Diseases
2
Melanoma
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Interventions
Technetium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
OTHER_GOV
×
Melanoma
×
Clear all
NCT07552597
2026-04-27
MagMen-II
Vastra Gotaland Region
Phase 3
Not yet recruiting
254 enrolled
NCT01785316
2024-01-26
SCANDIUM
Vastra Gotaland Region
Phase 3
Completed
93 enrolled